InnovaRx Innova Health Strategies

C88.90

Malignant immunoproliferative disease, unspecified not having achieved remission

Billable FY2026 2025-10-01 → 2026-09-30 FY2025–2027 only
This is the unspecified option. 1 more specific code sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 2 never code together
C88code
Excludes1
  • B-cell lymphoma, unspecified (C85.1-)C85.1-
  • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)Z85.79

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 14
C88.9code
Inclusion terms
  • Immunoproliferative disease NOS
C88.90code
Inclusion terms
  • Immunoproliferative disease NOS
  • Immunoproliferative disease NOS not having achieved remission
  • Immunoproliferative disease NOS with failed remission
  • Malignant immunoproliferative disease, unspecified NOS
  • Malignant immunoproliferative disease, unspecified with failed remission
C00-D49chapter
Notes
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).C25.9
Index entries leading here 1
  • Disease, diseased — see also Syndrome
    • immunoproliferative (malignant) C88.9
Alongside this code 1 same parent — C88.9
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC10 CMS28HCC21 ESRD21HCC10 ESRD24HCC10 RX08HCC21

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
C88.9
Block
C00-C96
Siblings
1

Present FY2025–FY2027.